Because the patient is the index case, he should be tested first. If the patient is found to have a genetic mutation associated with a familial form of renal cell carcinoma, then his brother should be tested. If the brother is found to have the same mutation, his offspring should be tested as well. If results of genetic testing on the case patient are negative, other family members should not be tested.
